BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2161149)

  • 1. Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease.
    Belsham GJ; Brangwyn JK; Ryan MD; Abrams CC; King AM
    Virology; 1990 Jun; 176(2):524-30. PubMed ID: 2161149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system.
    Abrams CC; King AM; Belsham GJ
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3089-98. PubMed ID: 8847514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors.
    Roosien J; Belsham GJ; Ryan MD; King AM; Vlak JM
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1703-11. PubMed ID: 2167924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing.
    Ryan MD; Belsham GJ; King AM
    Virology; 1989 Nov; 173(1):35-45. PubMed ID: 2554577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts.
    Vakharia VN; Devaney MA; Moore DM; Dunn JJ; Grubman MJ
    J Virol; 1987 Oct; 61(10):3199-207. PubMed ID: 3041041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and characterization of foot-and-mouth disease virus empty capsid particles expressed within mammalian cells.
    Gullberg M; Muszynski B; Organtini LJ; Ashley RE; Hafenstein SL; Belsham GJ; Polacek C
    J Gen Virol; 2013 Aug; 94(Pt 8):1769-1779. PubMed ID: 23740480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.
    Ypma-Wong MF; Semler BL
    J Virol; 1987 Oct; 61(10):3181-9. PubMed ID: 3041039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells.
    Belsham GJ; Abrams CC; King AM; Roosien J; Vlak JM
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():747-51. PubMed ID: 1848606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells.
    Polacek C; Gullberg M; Li J; Belsham GJ
    J Gen Virol; 2013 Jun; 94(Pt 6):1249-1258. PubMed ID: 23364188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli.
    Bablanian GM; Grubman MJ
    Virology; 1993 Nov; 197(1):320-7. PubMed ID: 8212567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.
    Chinsangaram J; Beard C; Mason PW; Zellner MK; Ward G; Grubman MJ
    J Virol; 1998 May; 72(5):4454-7. PubMed ID: 9557740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of "self-tagged" particles.
    Gullberg M; Polacek C; Bøtner A; Belsham GJ
    J Virol; 2013 Nov; 87(21):11591-603. PubMed ID: 23966400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing and assembly of foot-and-mouth disease virus proteins using subgenomic RNA.
    Clarke BE; Sangar DV
    J Gen Virol; 1988 Sep; 69 ( Pt 9)():2313-25. PubMed ID: 2842438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors.
    Parks GD; Palmenberg AC
    J Virol; 1987 Dec; 61(12):3680-7. PubMed ID: 2824807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A.
    Turner PC; Young DC; Flanegan JB; Moyer RW
    Virology; 1989 Dec; 173(2):509-21. PubMed ID: 2556841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of foot-and-mouth disease virus capsid precursor protein and 3C protease expression on bovine herpesvirus 1 replication.
    Klopfleisch C; Minh LQ; Giesow K; Curry S; Keil GM
    Arch Virol; 2010 May; 155(5):723-31. PubMed ID: 20333533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs.
    Sanz-Parra A; Jimenez-Clavero MA; García-Briones MM; Blanco E; Sobrino F; Ley V
    Virology; 1999 Jun; 259(1):129-34. PubMed ID: 10364496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.